| Symbol |
Name |
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
|
AKAP11
|
A kinase (PRKA) anchor protein 11
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
AR
|
androgen receptor
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
AXIN1
|
axin 1
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTD
|
biotinidase
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CCND1
|
cyclin D1
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1D
|
casein kinase 1, delta
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL4A
|
cullin 4A
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DRD3
|
dopamine receptor D3
|
|
E2F1
|
E2F transcription factor 1
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EPM2A
|
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FAS
|
Fas cell surface death receptor
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FGF19
|
fibroblast growth factor 19
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAA
|
glucosidase, alpha; acid
|
|
GBE1
|
glucan (1,4-alpha-), branching enzyme 1
|
|
GCG
|
glucagon
|
|
GLI3
|
GLI family zinc finger 3
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GPHN
|
gephyrin
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GYG1
|
glycogenin 1
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
HDAC2
|
histone deacetylase 2
|
|
HFE
|
hemochromatosis
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4
|
|
LIPE
|
lipase, hormone-sensitive
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MIR149
|
microRNA 149
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NDEL1
|
nudE neurodevelopment protein 1-like 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NHLRC1
|
NHL repeat containing E3 ubiquitin protein ligase 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOX3
|
NADPH oxidase 3
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARD6A
|
par-6 family cell polarity regulator alpha
|
|
PCGF6
|
polycomb group ring finger 6
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PGR
|
progesterone receptor
|
|
PHKA1
|
phosphorylase kinase, alpha 1 (muscle)
|
|
PHKG2
|
phosphorylase kinase, gamma 2 (testis)
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPM1F
|
protein phosphatase, Mg2+/Mn2+ dependent, 1F
|
|
PPP1R2
|
protein phosphatase 1, regulatory (inhibitor) subunit 2
|
|
PPP1R3A
|
protein phosphatase 1, regulatory subunit 3A
|
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PSEN1
|
presenilin 1
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PYGB
|
phosphorylase, glycogen; brain
|
|
PYGL
|
phosphorylase, glycogen, liver
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RELN
|
reelin
|
|
RORA
|
RAR-related orphan receptor A
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SDHAF2
|
succinate dehydrogenase complex assembly factor 2
|
|
SGK3
|
serum/glucocorticoid regulated kinase family, member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SMAD3
|
SMAD family member 3
|
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
STMN3
|
stathmin-like 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRIB3
|
tribbles pseudokinase 3
|
|
TRIM29
|
tripartite motif containing 29
|
|
TRIM63
|
tripartite motif containing 63, E3 ubiquitin protein ligase
|
|
TRIM7
|
tripartite motif containing 7
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
UGP2
|
UDP-glucose pyrophosphorylase 2
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
VWF
|
von Willebrand factor
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZCCHC8
|
zinc finger, CCHC domain containing 8
|
